VIX
7
-18
JNJ
39
4
MCO
73
5
ECL
57
3
IBM
54
3
HPQ
57
2
THC
53
3
LMT
44
5
K
53
5
SPG
50
4
SYF
83
7
SJM
21
2
PLD
40
2
AIV
40
3
GOOG
83
4
USB
50
4
GWW
51
3
NDAQ
50
4
D
35
2
AMG
52
3
VIX
7
-18
JNJ
39
4
MCO
73
5
ECL
57
3
IBM
54
3
HPQ
57
2
THC
53
3
LMT
44
5
K
53
5
SPG
50
4
SYF
83
7
SJM
21
2
PLD
40
2
AIV
40
3
GOOG
83
4
USB
50
4
GWW
51
3
NDAQ
50
4
D
35
2
AMG
52
3
Financhill
Back

Caesarstone 10K Form

Sell
36

CSTE
Caesarstone

Last Price:
$4.48
Seasonality Move:
4.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CSTE News And Ratings

See the #1 stock for the next 7 days that we like better than CSTE

CSTE Financial Statistics

Sales & Book Value

Annual Sales: $565.2M
Cash Flow: $12.4M
Price / Cash Flow: 4.14
Annual Sales: $8.87
Price / Book: 0.51

Profitability

EPS (TTM): -2.01000
Net Income (TTM): $-69M
Gross Margin: $91.9M
Return on Equity: -21.29%
Return on Assets: -11.94%

Caesarstone Earnings Forecast

Key Caesarstone Financial Ratios

  • The Gross Profit Margin over the past 14 years for CSTE is 16.27%.
  • The Selling, General & Administrative Expenses for CSTE have been equal to 23.30% of Gross Profit Margin.
  • The Research & Development expenses have been 0.90% of Revenue.
  • The Interest Expense is -4.95% of Operating Income.
  • The Net Earning history of CSTE is -19.05% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 4 years.

Caesarstone Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Building Products
Sector: Industrials
Current Symbol: CSTE
CUSIP: M20598
Website: caesarstone.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 2.55
Quick Ratio: 1.77

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CSTE Technical Analysis vs Fundamental Analysis

Sell
36
Caesarstone (CSTE) is a Sell

Is Caesarstone a Buy or a Sell?

  • Caesarstone stock is rated a Sell
    The current Caesarstone [CSTE] share price is $4.49. The Score for CSTE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.